Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001816389 | SCV002062579 | uncertain significance | not provided | 2021-11-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002542479 | SCV003640164 | uncertain significance | Inborn genetic diseases | 2022-09-06 | criteria provided, single submitter | clinical testing | The c.968A>G (p.Q323R) alteration is located in exon 5 (coding exon 5) of the TRIO gene. This alteration results from a A to G substitution at nucleotide position 968, causing the glutamine (Q) at amino acid position 323 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Molecular Genetics Lab, |
RCV003883185 | SCV004697779 | uncertain significance | Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome; Intellectual developmental disorder, autosomal dominant 63, with macrocephaly | criteria provided, single submitter | clinical testing |